Vaccines based on mRNA, first used for covid-19, may soon protect people from the influenza virus as well. This week, Moderna announced the start of a phase I/II trial testing out its vaccine candidate for the seasonal flu. Ultimately, the company hopes to develop a combination vaccine that can offer protection…